Association of low repair efficiency with high honnone receptors expression and SOD activity in breast cancer patients

被引:14
作者
Agnoletto, Mateus H.
Guecheva, Temenouga N.
Donde, Fernanda
de Oliveira, Adriana F.
Franke, Fabio
Cassini, Carina
Salvador, Mirian
Henriques, Joao A. P.
Saffi, Jenifer
机构
[1] Univ Luterana Brasil, Lab Genet Toxicol, BR-92425900 Canoas, RS, Brazil
[2] Univ Caxias do Sul, Inst Biotecnol, Caxias Do Sul, RS, Brazil
[3] Hosp Caridade Ijui, Ctr Complexidade Omcol, Ijui, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil
关键词
breast cancer; DNA damage; DNA repair; comet assay; catalase; superoxide dismutase; estrogen receptor; progesterone receptor;
D O I
10.1016/j.clinbiochem.2007.08.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To evaluate the antioxidant status and repair capacity in breast cancer patients as well as the relationship between these parameters and expression of critical proteins in breast cancer tissue. Design and methods: Blood samples were obtained from 25 female breast cancer patients and 19 healthy women. The antioxidant status was determined by the concentration of thiobarbituric-reactive substances (TBARS) and activity of superoxide dismutase (SOD) and catalase (CAT). The basal DNA damage and repair capacity in lymphocytes were evaluated by comet assay. The expression of p53, c-erbB2, Ki-67, estrogen receptor (ER) and progesterone receptor (PR) in cancer tissue was detected by immumohistochemical staining. Results: The breast cancer patients presented significantly elevated endogenous DNA damage in lymphocytes and lower susceptibility to DNA damage induced by H2O2 when compared to the control group. There is a negative correlation between TBARS and sensitivity to peroxide induced DNA damage in patients. The percentage of residual damage after H2O2 treatment followed by 3h of post-incubation is significantly higher in patients and also correlates positively with SOD activity, ER and PR expression and negatively with the basal DNA damage. Conclusions: Our results demonstrate low repair capacity in lymphocytes of breast cancer patients and suggest that the regulation of DNA repair is sensitive to cellular redox state and can be modulated by ER/PR status. (C) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1252 / 1258
页数:7
相关论文
共 30 条
  • [1] BLASIAK J, 2004, MUTAT RES, V554, P39
  • [2] The p53 story: layers of complexity
    Braithwaite, AW
    Royds, JA
    Jackson, P
    [J]. CARCINOGENESIS, 2005, 26 (07) : 1161 - 1169
  • [3] Repair of oxidative DNA damage: assessing its contribution to cancer prevention
    Collins, A
    Harrington, V
    [J]. MUTAGENESIS, 2002, 17 (06) : 489 - 493
  • [4] Biomolecular features of clinical relevance in breast cancer
    Daidone, MG
    Paradiso, A
    Gion, M
    Harbeck, N
    Sweep, F
    Schmitt, M
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (Suppl 1) : S3 - S14
  • [5] DAIDONE MG, 2001, J NATL CANC I MONOGR, V30, P2735
  • [6] Understanding breast cancer risk - where do we stand in 2005?
    Dumitrescu, RG
    Cotarla, I
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (01) : 208 - 221
  • [7] Oxidative DNA damage and antioxidant vitamin level: Comparison among lung cancer patients, healthy smokers and nonsmokers
    Gackowski, D
    Kowalewski, J
    Siomek, A
    Olinski, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) : 153 - 156
  • [8] Apoptotic markers in cancer
    Holdenrieder, S
    Stieber, P
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (07) : 605 - 617
  • [9] Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
    Itagaki, T
    Shimizu, I
    Cheng, X
    Yuan, Y
    Oshio, A
    Tamaki, K
    Fukuno, H
    Honda, H
    Okamura, Y
    Ito, S
    [J]. GUT, 2005, 54 (12) : 1782 - 1789
  • [10] Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients
    Kröger, N
    Milde-Langosch, K
    Riethdorf, S
    Schmoor, C
    Schumacher, M
    Zander, AR
    Löning, T
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (01) : 159 - 168